financetom
Business
financetom
/
Business
/
Never spoke to Elon Musk on buying Tesla, says Tim Cook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Never spoke to Elon Musk on buying Tesla, says Tim Cook
Apr 6, 2021 5:53 AM

Did Elon Musk try to sell Tesla to Apple? Well, Tim Cook, the Chief Executive Officer (CEO) of Apple Inc., said that he’s “never spoken to Elon. "Although I have great admiration and respect for the company he’s built," he added.

Musk had once claimed that he tried to hold talks about the possibility of selling Tesla to Apple. During the New York Times “Sway” podcast that was released Monday, Cook, while suggesting that a change may be on the horizon, said that Tesla has “done an unbelievable job of not only establishing the lead, but keeping the lead for such a long period of time in the EV space.”

Cook, who has been with Apple for 23 years, holding the position of the company’s CEO for almost 10 years now, also said during the podcast appearance that at 60, he doubts if he’d be in the company for 10 more years. “I feel great right now. And the date’s not in sight. But 10 more years is a long time and probably not 10 more years,” he said.

He, however, didn’t reveal much about the tech giant’s plans for the electric vehicle sector. “We'll see what Apple does. We investigate so many things internally. Many of them never see the light of day. I'm not saying that one will not,” he said.

Cook also talked about the controversial Parler social media app, blocked by Apple earlier this year. He said removing Parler from the App Store was a straightforward decision because they were not adhering to their guidelines. “You can't be inciting violence or allow people to incite violence. You can't allow hate speech. And they had moved from moderating to not being able to moderate. I'm hoping that they put in the moderation that's required to be on the store because having more social networks is better than having less,” he said.

The other topics that he broached upon were Apple TV+ and autonomous vehicles. On the role of social media in the attack on the US Capitol, he said that he was worried about its amplification. “The same tools that are used to target in advertising can be used for spreading misinformation or extremist views,” said Cook.

He went on to say that he was appalled by data theft and that they would improve the privacy policy over time. “Privacy policies have become these multi-page things that people just blindly click to ‘I agree’, so that they can go to the next screen page. A privacy nutrition label, much like a nutrition label on food, gives you some key information at a glance.”

Before signing off, the Apple CEO also talked about voting rights. “I think we're probably all having the wrong conversation on voting rights. We should be talking about using technology. How can we make it so simple that our voting participation gets to 100 or really close?” he said.

(Edited by : Aditi Gautam)

First Published:Apr 6, 2021 2:53 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Milestone Pharmaceuticals' Partner Ji Xing's Phase 3 Trial of Etripamil Meets Primary Endpoint
Milestone Pharmaceuticals' Partner Ji Xing's Phase 3 Trial of Etripamil Meets Primary Endpoint
Sep 6, 2024
09:08 AM EDT, 09/06/2024 (MT Newswires) -- Milestone Pharmaceuticals ( MIST ) said Friday that its licensing partner Ji Xing Pharmaceuticals reported that a phase 3 trial in China evaluating etripamil nasal spray to treat paroxysmal supraventricular tachycardia met its primary endpoint. Ji Xing said the results show a statistically significant greater proportion of patients who took etripamil converted PSVT...
Market Chatter: Taiwan Semiconductor's Arizona Trials Match Taiwanese Plants' Productivity
Market Chatter: Taiwan Semiconductor's Arizona Trials Match Taiwanese Plants' Productivity
Sep 6, 2024
09:10 AM EDT, 09/06/2024 (MT Newswires) -- Taiwan Semiconductor Manufacturing ( TSM ) achieved productivity levels at its Arizona facility on par with its Taiwan-based plants, an indicator its big US project is on the right path, Bloomberg reported, citing a person familiar with the matter. In trial production at its first advanced US plant, the chipmaker's yield rate was...
Ventyx Biosciences Doses First Patient in Phase 2a Parkinson's Drug Trial
Ventyx Biosciences Doses First Patient in Phase 2a Parkinson's Drug Trial
Sep 6, 2024
09:00 AM EDT, 09/06/2024 (MT Newswires) -- Ventyx Biosciences ( VTYX ) said Friday it has dosed the first patient in a phase 2a trial of its drug candidate VTX3232 for early-stage Parkinson's disease. The company said the study will assess the safety and tolerability of VTX3232, a selective NLRP3 inhibitor, over a 28-day treatment period involving about 10 patients....
Guidewire Q4 Beats Estimates, Revenue And ARR Surge
Guidewire Q4 Beats Estimates, Revenue And ARR Surge
Sep 6, 2024
Guidewire Software, Inc. ( GWRE ) shares are trading higher after the company reported fourth-quarter results on Thursday. Total revenue rose 8% Y/Y to $291.5 million, beating the consensus of $283.9 million. Subscription and support revenue increased by 29% Y/Y to $151.8 million, while license revenue decreased by 12% Y/Y to $88.9 million. Also, Services revenue fell by 2% to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved